Dec 20, 2019
1:1000
For every 1000 shares held, investors received 1. The price per share adjusted from $0.00 to $1.30.
The split itself did not change the total investment value.
Endonovo Therapeutics, Inc. (OTC:ENDV) operates in the Medical specialties industry.
Endonovo Therapeutics, Inc. company overviewEndonovo Therapeutics, Inc.'s most recent stock split was on December 20, 2019. It was a 1-for-1000 reverse split, so shareholders received 1 share for every 1000 they held.
Endonovo Therapeutics, Inc. (OTC:ENDV) has split its stock 2 times: a 1-for-100 reverse split on May 15, 2014 and a 1-for-1000 reverse split on December 20, 2019.
Endonovo Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between May 15, 2014 and December 20, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Endonovo Therapeutics, Inc.'s 1-for-1000 reverse split on December 20, 2019, every 1000 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Endonovo Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on December 20, 2019, 6 years ago. Companies announce splits in advance, and any new OTC:ENDV split will appear on this page.